CannLabs, Inc.
CANL · OTC
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 12.1% | 4.4% | 4.7% | – |
| Cost of Goods Sold | $1 | $1 | $1 | $0 |
| Gross Profit | $1 | $0 | $0 | $1 |
| % Margin | 52.1% | 36.5% | 43.4% | 55.8% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | $0 | $0 | $0 | $0 |
| % Margin | 29.6% | 9.4% | 10.7% | 29% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | $0 | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 29.5% | 9.3% | 10.6% | 28.9% |
| EPS | 0 | 0 | 0 | 0 |
| % Growth | 300% | 0% | -75% | – |
| EPS Diluted | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out | 813 | 813 | 813 | 813 |
| Weighted Avg Shares Out Dil | 813 | 813 | 813 | 813 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 29.8% | 9.6% | 10.9% | 29.2% |